Doaa A. Elsayed

Dr. Doaa A. Elsayed

Chemistry, Zagazig University, Zagazig, Egypt
orcid
Lecturer of organic chemistry / zagazig university

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Medicinal Chemistry Research
Verified
Journal Article
Open access
PDF file
WSWesam Saber Shehab
Wesam Saber Shehab
MAMostafa M. K. Amer
Mostafa M. K. Amer
Doaa A. ElsayedDoaa A. Elsayed
Doaa A. Elsayed
KYKrishna Kumar Yadav
Krishna Kumar Yadav
MAMagda Abdellattif
Magda Abdellattif
Quinoline motifs are essential in several pharmacological active heterocyclic compounds due to their various applications in medicinal and industrial chemistry. Furthermore, there are greater societal expectations in the current scenario that synthetic and medicinal chemists should produce greener and more sustainable chemical processes. Therefore, this mini-review article highlights the traditional and green synthetic approaches of quinoline and its analogs, including multicomponent one-pot reactions and solvent-free reaction conditions utilizing microwave and ultraviolet irradiation-promoted synthesis using eco-friendly and safe reusable catalysts, in addition to discussing the medicinal importance of quinoline derivatives such as anticancer, antioxidant, anti-inflammatory, antimalarial, anti-SARS-CoV-2, and antituberculosis activities within the period from 2011 till 2021. Therefore, the quinoline scaffolds signify a unique class of pharmacophores present in various therapeutic agents.

29 May 2025 in RSC Advances
Verified
Journal Article
Open access
.A. Bassant Farag Abdo
. Bassant Farag Abdo
MZMagdi Zaki
Magdi Zaki
Doaa A. ElsayedDoaa A. Elsayed
Doaa A. Elsayed
Sobhi M. GomhaSobhi M. Gomha
Sobhi M. Gomha
Benzimidazole is crucial in drug design, with derivatives showing anticancer activity via DNA interaction and enzyme inhibition; SAR studies aim to improve efficacy, selectivity, and reduce toxicity.

18 January 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WSWesam Saber Shehab
Wesam Saber Shehab
Doaa A. ElsayedDoaa A. Elsayed
Doaa A. Elsayed
AHAtef M. Abdel Hamid
Atef M. Abdel Hamid
MAMohamed G. Assy
Mohamed G. Assy
SMSamar M. Mouneir
Samar M. Mouneir
GEGehan T. El-Bassyouni
Gehan T. El-Bassyouni
Helicobacter pylori (H. pylori) is a universal health intimidation as mentioned by the World Health Organization. The primary causal agent linked to a number of illnesses, including inflammation and the development of stomach ulcers, is Helicobacter pylori. Since, H. pylori develops antibiotic resistance quickly, current H. pylori treatment approaches are becoming less effective. Our research aims to highlight novel formulation antibiotics using CuO-NPs as catalysts and studied their activity as anti-helicobacter pylori supported by computational studies (POM analysis and molecular docking) software. They were designed for anti-Helicobacter Pylori action. All compounds revealed a bactericidal effect better than the reference McFarland standards.

25 July 2025 in Scientific Reports
Verified
Journal Article
Open access
MMMohammed A. Marzouk
Mohammed A. Marzouk
EMElsayed M. Mahmoud
Elsayed M. Mahmoud
WSWesam Saber Shehab
Wesam Saber Shehab
SFSherif M. Fawzy
Sherif M. Fawzy
SMSamar Mohammed Mohammed
Samar Mohammed Mohammed
Doaa A. ElsayedDoaa A. Elsayed
Doaa A. Elsayed
The development of effective antidiabetic agents remains a critical challenge in diabetes management. In this study, we introduce novel 1,2,4-triazole-based derivatives designed as dual inhibitors of α-amylase and α-glucosidase, key enzymes in carbohydrate metabolism. Molecular docking identified six promising candidates, with compounds 4 and 10 showing the highest potency. Both compounds exhibited strong α-glucosidase inhibition (IC50 = 0.27 ± 0.01 µg/mL and 0.31 ± 0.01 μg/mL, respectively), surpassing acarbose, and also demonstrated potent α-amylase inhibition (IC50 = 0.19 ± 0.01 μg/mL and 0.26 ± 0.01 μg/mL, respectively). Structure–activity relationship analysis highlighted the crucial role of acetyl and bromo substituents in enhancing enzyme inhibition. These findings position triazole-based scaffolds as promising candidates for the development of next-generation antidiabetic therapies.

27 March 2025 in Journal of Molecular Structure
Verified
Journal Article
Closed access
WSWesam S. Shehab
Wesam S. Shehab
NMNaja Magdy
Naja Magdy
MEMuhammed A.R. Elhoseni
Muhammed A.R. Elhoseni
MAMohamed G. Assy
Mohamed G. Assy
MAMohamed H.M. AbdEl-Azim
Mohamed H.M. AbdEl-Azim
Doaa A. ElsayedDoaa A. Elsayed
Doaa A. Elsayed

4 July 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WSWesam Saber Shehab
Wesam Saber Shehab
HHHend A. Haikal
Hend A. Haikal
Doaa A. ElsayedDoaa A. Elsayed
Doaa A. Elsayed
AEAhmed F. El-Farargy
Ahmed F. El-Farargy
AEAbdel-Rahman B. A. El-Gazzar
Abdel-Rahman B. A. El-Gazzar
SMSahar M. Mousa
Sahar M. Mousa
Alzheimer disease (AD) is the cause of dementia and accounts for 60–80% cases. Tumor Necrosis Factor-alpha (TNF-α) is a multifunctional cytokine that provides resistance to infections, inflammation, and cancer. It developed as a prospective therapeutic target against multiple autoimmune and inflammatory disorders. Cholinergic insufficiency is linked to Alzheimer's disease, and several cholinesterase inhibitors have been created to treat it, including naturally produced inhibitors, synthetic analogs, and hybrids. In the current study, we tried to prepared compounds may also support the discovery and development of novel therapeutic and preventative drugs for Alzheimer's using manganese tetroxide nanoparticles (Mn3O4-NPs) as a catalyst to generate compounds with excellent reaction conditions. The Biginelli synthesis yields 4-(4-cyanophenyl)-6-oxo-2-thioxohexahydropyrimidine-5-carbonitrile when the 4-cyanobenzaldehyde, ethyl cyanoacetate, and thiourea were coupled with Mn3O4-NPs to produce compound 1. This multi-component method is non-toxic, safe, and environmentally friendly. The new approach reduced the amount of chemicals used and preserved time. Compound 1 underwent reactions with methyl iodide, acrylonitrile, chloroacetone, ethyl chloroacetate, and chloroacetic acid/benzaldehyde, each of the synthetized compounds was docked with TNF-α converting enzyme. These compounds may also support the discovery and development of novel therapeutic and preventative drugs for Alzheimer's disease. The majority of the produced compounds demonstrated pharmacokinetic features, making them potentially attractive therapeutic candidates for Alzheimer's disease treatment.